Health ❯ Healthcare ❯ Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease Cognitive Decline Amyloid-beta Proteins Research Innovations Biomarkers Plasmaféresis Patient Support Programs Diagnosis and Treatment Risk Assessment Treatment Strategies Amyloid Beta Targeting Mild Cognitive Impairment Disease Progression Research Studies Diagnosis Methods Aging-related Treatments Symptoms and Diagnosis

UK Approves Once-Every-Four-Weeks IV Maintenance Dosing for Leqembi in Early Alzheimer’s

The decision follows Phase 3 evidence, aligning the UK regimen with other major markets.

First Noninvasive MRI Maps Brain’s Tiniest Vessel Pulses, Tying Aging and Hypertension to Deep White Matter

Harvard Team Releases PDGrapher, an AI to Predict Gene and Drug Combos That Reverse Diseased Cell States

Alzheimer’s Biomarkers Emerge in Middle Age With Maternal and Kidney Associations